92 related articles for article (PubMed ID: 3808471)
21. The regional distribution of neurotensin-like immunoreactivity in central and peripheral tissues of the cat.
Goedert M; Emson PC
Brain Res; 1983 Aug; 272(2):291-7. PubMed ID: 6616204
[TBL] [Abstract][Full Text] [Related]
22. Characterization of neuromedin U like immunoreactivity in rat, porcine, guinea-pig and human tissue extracts using a specific radioimmunoassay.
Domin J; Ghatei MA; Chohan P; Bloom SR
Biochem Biophys Res Commun; 1986 Nov; 140(3):1127-34. PubMed ID: 3778484
[TBL] [Abstract][Full Text] [Related]
23. Distribution of a putative endogenous modulator of the GABAergic system in human brain.
Ferrarese C; Appollonio I; Frigo M; Piolti R; Tamma F; Frattola L
Neurology; 1989 Mar; 39(3):443-5. PubMed ID: 2927661
[TBL] [Abstract][Full Text] [Related]
24. Distribution of substance K (neurokinin A) in the brain and peripheral tissues of rats.
Takano Y; Nagashima A; Masui H; Kuromizu K; Kamiya HO
Brain Res; 1986 Mar; 369(1-2):400-4. PubMed ID: 2421847
[TBL] [Abstract][Full Text] [Related]
25. Distribution of galanin-like immunoreactivity in the pig, rat and human central nervous system.
Michener SR; Aimone LD; Yaksh TL; Go VL
Peptides; 1990; 11(6):1217-23. PubMed ID: 1708138
[TBL] [Abstract][Full Text] [Related]
26. Cerebellin-like peptide: tissue distribution in rat and guinea-pig and its release from rat cerebellum, hypothalamus and cerebellar synaptosomes in vitro.
Burnet PW; Bretherton-Watt D; Ghatei MA; Bloom SR
Neuroscience; 1988 May; 25(2):605-12. PubMed ID: 3399060
[TBL] [Abstract][Full Text] [Related]
27. Co-localization and co-release of GABA and putative allosteric modulators of GABA receptor.
Ferrarese C; Alho H; Guidotti A; Costa E
Neuropharmacology; 1987 Jul; 26(7B):1011-8. PubMed ID: 2821427
[TBL] [Abstract][Full Text] [Related]
28. [The distribution, characteristics and effects of ir-BNP in central and peripheral tissues in rat].
Tang JA; Cui H; Xu D; Li CY; Wang JP; Meng ZH; Peng JY; Yuan QX; Zhang D; Zhang ZK
Sheng Li Xue Bao; 1989 Jun; 41(3):215-22. PubMed ID: 2781306
[TBL] [Abstract][Full Text] [Related]
29. Diazepam binding inhibitor fragment 33-50 (octadecaneuropeptide) immunoreactivity in the cerebellar cortex is restricted to glial cells.
Vidnyánszky Z; Görcs TJ; Hámori J
Glia; 1994 Feb; 10(2):132-41. PubMed ID: 8168866
[TBL] [Abstract][Full Text] [Related]
30. Role of glucocorticoids in the modulation of corticotropin-releasing hormone mRNA level by the endogenous benzodiazepine receptor ligand octadecaneuropeptide in rat brain.
Givalois L; Li S; Pelletier G
Neuroendocrinology; 1998 Aug; 68(2):98-104. PubMed ID: 9705576
[TBL] [Abstract][Full Text] [Related]
31. Studies of a brain polypeptide functioning as a putative endogenous ligand to benzodiazepine recognition sites in rats selectively bred for alcohol related behavior.
Alho H; Miyata M; Korpi E; Kiianmaa K; Guidotti A
Alcohol Alcohol Suppl; 1987; 1():637-41. PubMed ID: 3426746
[TBL] [Abstract][Full Text] [Related]
32. Effect of the diazepam-binding inhibitor-derived peptide, octadecaneuropeptide, on food intake in goldfish.
Matsuda K; Wada K; Miura T; Maruyama K; Shimakura SI; Uchiyama M; Leprince J; Tonon MC; Vaudry H
Neuroscience; 2007 Dec; 150(2):425-32. PubMed ID: 17936516
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake.
do Rego JC; Orta MH; Leprince J; Tonon MC; Vaudry H; Costentin J
Neuropsychopharmacology; 2007 Jul; 32(7):1641-8. PubMed ID: 17151595
[TBL] [Abstract][Full Text] [Related]
34. Protracted treatment with diazepam increases the turnover of putative endogenous ligands for the benzodiazepine/beta-carboline recognition site.
Miyata M; Mocchetti I; Ferrarese C; Guidotti A; Costa E
Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1444-8. PubMed ID: 3029781
[TBL] [Abstract][Full Text] [Related]
35. Bombesin-like immunoreactivity in the central nervous system of capsaicin-treated rats: a radioimmunoassay and immunohistochemical study.
Decker MW; Towle AC; Bissette G; Mueller RA; Lauder JM; Nemeroff CB
Brain Res; 1985 Sep; 342(1):1-8. PubMed ID: 2412638
[TBL] [Abstract][Full Text] [Related]
36. Diazepam binding inhibitor (DBI): a peptide with multiple biological actions.
Costa E; Guidotti A
Life Sci; 1991; 49(5):325-44. PubMed ID: 1649940
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of endozepine-like immunoreactivity in the frontal cortex of suicide victims.
Rochet T; Tonon MC; Kopp N; Vaudry H; Miachon S
Neuroreport; 1998 Jan; 9(1):53-6. PubMed ID: 9592047
[TBL] [Abstract][Full Text] [Related]
38. Identification, characterization and distribution of motilin immunoreactivity in the rat central nervous system.
O'Donohue TL; Beinfeld MC; Chey WY; Chang TM; Nilaver G; Zimmerman EA; Yajima H; Adachi H; Poth M; McDevitt RP; Jacobowitz DM
Peptides; 1981; 2(4):467-77. PubMed ID: 7329825
[TBL] [Abstract][Full Text] [Related]
39. Regional distribution of a novel peptide (P7 of 1B236) immunoreactivity in the human central nervous system.
Suzuki H; Ghatei MA; Reynolds GP; Anand P; Bloom SR
Neurosci Lett; 1986 Jun; 67(1):58-62. PubMed ID: 3725201
[TBL] [Abstract][Full Text] [Related]
40. The regional distribution and chromatographic characterisation of neurotensin-like immunoreactivity in the rat central nervous system.
Emson PC; Goedert M; Horsfield P; Rioux F; St Pierre S
J Neurochem; 1982 Apr; 38(4):992-9. PubMed ID: 7062044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
